Posttranslational modifications in regulating Notch signaling pathway and tumor angiogenesis: from molecular

Jiaan Wang1, Meng Zhang1, Donglai Wang1

  • 1State Key Laboratory of Common Mechanism Research for Major Diseases & Department of Medical Genetics, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.

PubMed

Insights

Targeting Notch signaling pathway posttranslational modifications (PTMs) offers a novel strategy to control tumor angiogenesis. Understanding these PTMs is crucial for developing effective cancer therapies with reduced toxicity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumorigenesis involves intricate interactions with the vascular system, making angiogenesis a key therapeutic target.
  • The Notch signaling pathway regulates tumor angiogenesis but faces clinical translation challenges due to toxicity.
  • Posttranslational modifications (PTMs) critically influence Notch signaling integrity and function.

Purpose of the Study:

  • To explore the crosstalk between Notch signaling and tumor angiogenesis.
  • To investigate the regulatory roles of PTMs on Notch molecules in tumor angiogenesis.
  • To evaluate the therapeutic potential of targeting Notch-related PTMs for anti-angiogenic cancer strategies.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of molecular mechanisms linking PTMs, Notch signaling, and angiogenesis.
  • Discussion of therapeutic challenges and clinical translation barriers.

Main Results:

  • Notch signaling is a central regulator of tumor angiogenesis.
  • Specific PTMs like glycosylation and ubiquitination are vital for Notch pathway integrity.
  • Dysfunctional Notch-related PTMs contribute to pathological angiogenesis.

Conclusions:

  • Targeting Notch-related PTMs presents a promising avenue for anti-angiogenic cancer therapy.
  • Elucidating the PTMs-Notch-angiogenesis nexus is key for tumor progression understanding.
  • Overcoming clinical translation barriers for PTM-targeted therapies is essential for oncology.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K